215 related articles for article (PubMed ID: 33774058)
1. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.
Corradini E; Buzzetti E; Dongiovanni P; Scarlini S; Caleffi A; Pelusi S; Bernardis I; Ventura P; Rametta R; Tenedini E; Tagliafico E; Fracanzani AL; Fargion S; Pietrangelo A; Valenti LV
J Hepatol; 2021 Sep; 75(3):506-513. PubMed ID: 33774058
[TBL] [Abstract][Full Text] [Related]
2. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
Branisso PPF; de Oliveira CPMS; Filho HML; Lima FR; Santos AS; Mancini MC; de Melo ME; Carrilho FJ; Rocha MS; Clark P; Branisso HJP; Cercato C
Ann Hepatol; 2022; 27(4):100707. PubMed ID: 35477031
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.
Buzzetti E; Petta S; Manuguerra R; Luong TV; Cabibi D; Corradini E; Craxì A; Pinzani M; Tsochatzis E; Pietrangelo A
Liver Int; 2019 Jul; 39(7):1325-1334. PubMed ID: 30851216
[TBL] [Abstract][Full Text] [Related]
6. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
Valenti L; Canavesi E; Galmozzi E; Dongiovanni P; Rametta R; Maggioni P; Maggioni M; Fracanzani AL; Fargion S
J Hepatol; 2010 Nov; 53(5):927-33. PubMed ID: 20739079
[TBL] [Abstract][Full Text] [Related]
7. The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.
Valenti L; Rametta R; Dongiovanni P; Motta BM; Canavesi E; Pelusi S; Pulixi EA; Fracanzani AL; Fargion S
PLoS One; 2012; 7(11):e48804. PubMed ID: 23144979
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
Valenti L; Dongiovanni P; Piperno A; Fracanzani AL; Maggioni M; Rametta R; Loria P; Casiraghi MA; Suigo E; Ceriani R; Remondini E; Trombini P; Fargion S
Hepatology; 2006 Oct; 44(4):857-64. PubMed ID: 17006922
[TBL] [Abstract][Full Text] [Related]
9. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
[TBL] [Abstract][Full Text] [Related]
10. Hepatic iron is the major determinant of serum ferritin in NAFLD patients.
Ryan JD; Armitage AE; Cobbold JF; Banerjee R; Borsani O; Dongiovanni P; Neubauer S; Morovat R; Wang LM; Pasricha SR; Fargion S; Collier J; Barnes E; Drakesmith H; Valenti L; Pavlides M
Liver Int; 2018 Jan; 38(1):164-173. PubMed ID: 28679028
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.
Valenti L; Dongiovanni P; Fargion S
World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.
Valenti L; Fracanzani AL; Dongiovanni P; Rovida S; Rametta R; Fatta E; Pulixi EA; Maggioni M; Fargion S
World J Gastroenterol; 2014 Mar; 20(11):3002-10. PubMed ID: 24659891
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing aceruloplasminemia: navigating through red herrings.
Kharel Z; Kharel H; Phatak PD
Ann Hematol; 2024 Jun; 103(6):2173-2176. PubMed ID: 38637332
[TBL] [Abstract][Full Text] [Related]
15. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
Rametta R; Fracanzani AL; Fargion S; Dongiovanni P
Curr Pharm Des; 2020; 26(10):1025-1035. PubMed ID: 32003680
[TBL] [Abstract][Full Text] [Related]
16. Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectional study from NHANES 2017-2018.
Tan L; Zhou Q; Liu J; Liu Z; Shi R
Food Funct; 2023 Jun; 14(12):5653-5662. PubMed ID: 37249386
[No Abstract] [Full Text] [Related]
17. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.
Kowdley KV; Belt P; Wilson LA; Yeh MM; Neuschwander-Tetri BA; Chalasani N; Sanyal AJ; Nelson JE;
Hepatology; 2012 Jan; 55(1):77-85. PubMed ID: 21953442
[TBL] [Abstract][Full Text] [Related]
18. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
[TBL] [Abstract][Full Text] [Related]
19. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin level is associated with liver fibrosis and incident liver-related outcomes independent of
Männistö VT; Hakkarainen K; Jula A; Lundqvist A; Vihervaara T; Erlund I; Åberg F
Scand J Gastroenterol; 2024 May; 59(5):592-599. PubMed ID: 38329447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
